. 1996;153:1530-1535.
34. Nagai A, West WW, Thurlbeck WM. The National Institutes of
studies: II. Correlation between morphologic findings, clinical
1985;132:946-953.
et al. Goblet cell hyperplasia and epithelial inflammation in pe-
doi:10.1164/ajrccm.161.3.9907080.
36. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutro-
doi:10.1172/JCI114492.
О.М., Дыханов И.И., Макарова С.А. Цитологическая харак-
50
АРХИВ ПАТОЛОГИИ, 1, 2016
38. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL
et al. COPD phenotypes: The future of COPD. Am J Respir Crit
Care Med
. 2010;182:598-604.
doi:10.1164/rccm.200912-1843CC.
39. Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E,
Rodríguez DA et al. Physical activity and clinical and functional
status in COPD. Chest. 2009;136(1):62-70.
doi:10.1378/chest.08-2532.
40. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman
J et al. The relations between structural changes in small airways
and pulmonary-function tests. N Engl J Med. 1978;298:1277-1281.
doi:10.1056/NEJM197806082982303.
41. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT,
Kauffman HF et al. Proteoglycan changes in the extracellular ma-
trix of lung tissue from patients with pulmonary emphysema. Mod
Pathol.
1999;12:697-705.
42. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M.
Airway structural alterations selectively associated with severe
asthma. Am J Respir Crit Care Med. 2003;167:1360-1368.
doi:10.1164/rccm.200209-1030OC.
43. Jeffery PK. Structural and inflammatory changes in COPD: a
comparison with asthma. Thorax. 1998;53:2129-136.
doi:10.1136/thx.53.2.129.
44. Jarai G, Sukkar M, Garrett S, Duroudier N, Westwick J, Adcock
I et al. Effects of interleukin-1beta, interleukin-13 and transform-
ing growth factor-beta on gene expression in human airway
smooth muscle using gene microarrays. Eur J Pharmacol.
2004;497:255-265.
doi:10.1016/j.ejphar.2004.06.055.
45. Howarth PH, Knox AJ, Amrani Y, Tliba O, Panettieri RA Jr,
Johnson M. Synthetic responses in airway smooth muscle. J Al
lergy Clin Immunol.
2004;114:32-50.
doi:10.1016/j.jaci.2004.04.041.
46. Tiddens HA, Pare PD, Hogg JC, Hop WC, Lambert R, De Jong-
ste JC. Cartilaginous airway dimensions and airflow obstruction
in human lungs. Am J Respir Crit Care Med. 1995;152:260-266.
doi:10.1164/ajrccm.152.1.7599833.
47. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC.
Small airways dimensions in asthma and in chronic obstructive
pulmonary disease. Am Rev Respir Dis. 1993;148:1220-1225.
doi:10.1164/ajrccm/148.5.1220.
48. Chung KF. The role of airway smooth muscle in the pathogenesis
of airway wall remodeling in chronic obstructive pulmonary dis-
ease. Symposium: the science of COPD: opportunities for combi-
nation therapy. Proc Am Thorac Soc. 2005;2(4):347-354.
doi:10.1513/pats.200504-028SR.
49. Lamb D. Chronic obstructive pulmonary disease: pathology. In:
Brewis RAL, Gibson GJ, Geddes DM, eds. Respiratory medicine.
London: Bailliere Tindall; 1990;497-507.
50. Kim WD, Eidelman DH, Izquierdo JL, Ghezzo H, Saetta MP,
Cosio MG. Centrilobular and panlobular emphysema in smokers.
Two distinct morphologic and functional entities. Am Rev Respir
Dis.
1991;144(6):1385-1390.
doi:10.1164/ajrccm/144.6.1385.
51. Finkelstein R, Ma HD, Ghezzo H, Whittaker K, Fraser RS, Cosio
MG. Morphometry of small airways in smokers and its relation-
ship to emphysema type and hyperresponsiveness. Am J Respir Crit
Достарыңызбен бөлісу: